BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21781406)

  • 1. Outcomes and safety of drug provocation tests.
    Aun MV; Bisaccioni C; Garro LS; Rodrigues AT; Tanno LK; Ensina LF; Kalil J; Motta AA; Giavina-Bianchi P
    Allergy Asthma Proc; 2011; 32(4):301-6. PubMed ID: 21781406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drug provocation tests in Korean children: a single center experience.
    Choi J; Lee JY; Kim KH; Choi J; Ahn K; Kim J
    Asian Pac J Allergy Immunol; 2016 Jun; 34(2):130-6. PubMed ID: 27007834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with drug reactions -- is it worth testing?
    Wöhrl S; Vigl K; Stingl G
    Allergy; 2006 Aug; 61(8):928-34. PubMed ID: 16867044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z
    Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provocation tests in diagnosing drug hypersensitivity.
    Bousquet PJ; Gaeta F; Bousquet-Rouanet L; Lefrant JY; Demoly P; Romano A
    Curr Pharm Des; 2008; 14(27):2792-802. PubMed ID: 18991698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience.
    Vezir E; Erkocoglu M; Civelek E; Kaya A; Azkur D; Akan A; Ozcan C; Toyran M; Ginis T; Misirlioglu ED; Kocabas CN
    Allergy Asthma Proc; 2014; 35(2):156-62. PubMed ID: 24717793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of patients undergoing drug provocation tests (DPTs).
    Thalayasingam M; Davies LJ; Llanora GV; Gerez IF; Van Bever HP; Shek LP
    Ann Acad Med Singap; 2013 Apr; 42(4):184-9. PubMed ID: 23677213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Safety of Drug Allergy Workups in a Spanish University Hospital: Drug Characteristics, Type of Reaction, and Patients' Age at the Initial Assessment.
    Peña-Acevedo Y; Rosado-Ingelmo A; Vargas Porras W; Brandoni-Petrone M; Tejedor-Alonso MA
    Int Arch Allergy Immunol; 2023; 184(4):353-365. PubMed ID: 36634625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provocation proven drug allergy in Thai children with adverse drug reactions.
    Indradat S; Veskitkul J; Pacharn P; Jirapongsananuruk O; Visitsunthorn N
    Asian Pac J Allergy Immunol; 2016 Mar; 34(1):59-64. PubMed ID: 26994627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining safe alternatives for multidrug hypersensitive patients with the alternative triple antibiotic-analgesic test.
    Ozturk AB; Celebioglu E; Karakaya G; Kalyoncu AF
    Allergol Immunopathol (Madr); 2013; 41(3):189-93. PubMed ID: 22559997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug allergy in a population of surgical patients].
    Escolano F; Bisbe E; Castillo J; López R; Parés N; Arilla M; Castaño J
    Rev Esp Anestesiol Reanim; 1998 Dec; 45(10):425-30. PubMed ID: 9927834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF).
    Salvo F; Polimeni G; Cutroneo PM; Leone R; Confortic A; Moretti U; Motola D; Tuccori M; Caputi AP
    Pharmacol Res; 2008; 58(3-4):202-7. PubMed ID: 18692136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' satisfaction with diagnostic drug provocation tests and perception of its usefulness.
    Gomes ER; Kvedariene V; Demoly P; Bousquet PJ
    Int Arch Allergy Immunol; 2011; 156(3):333-8. PubMed ID: 21720180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children.
    Topal E; Celiksoy MH; Catal F; Gamze Sayan Y; Sancak R
    Allergy Asthma Proc; 2016; 37(1):57-63. PubMed ID: 26831848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity to Ibuprofen: Real-Life Experience in Children with History of Suspected Immediate Reactions.
    Sipahi Cimen S; Yucel E; Suleyman A; Hizli Demirkale Z; Ozceker D; Sayili U; Guler N; Tamay Z
    Int Arch Allergy Immunol; 2023; 184(1):33-42. PubMed ID: 36282068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical method of drug provocation testing to prove tolerance to alternative drugs in drug hypersensitivity.
    Çelebioğlu E; Öztürk Aktaş Ö; Karakaya G; Kalyoncu AF
    Turk J Med Sci; 2021 Apr; 51(2):604-609. PubMed ID: 33021762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children.
    Arikoglu T; Aslan G; Yildirim DD; Batmaz SB; Kuyucu S
    Allergol Int; 2017 Jul; 66(3):418-424. PubMed ID: 27865769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010.
    Renaudin JM; Beaudouin E; Ponvert C; Demoly P; Moneret-Vautrin DA
    Allergy; 2013 Jul; 68(7):929-37. PubMed ID: 23741979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions.
    Hein UR; Chantraine-Hess S; Worm M; Zuberbier T; Henz BM
    Acta Derm Venereol; 1999 Mar; 79(2):139-42. PubMed ID: 10228634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.